Results 91 to 100 of about 33,657 (222)
An Uncommon Case of Ecthyma Gangrenosum in a Three‐Year‐Old Immunocompetent Child
Clinical Case Reports, Volume 14, Issue 6, June 2026.The necrotic lesions on day 10. ABSTRACT Ecthyma gangrenosum (EG) is a rare cutaneous finding of Pseudomonas aeruginosa sepsis, typically in immunocompromised patients. We present EG with septic shock in a previously healthy three‐year‐old child who presented with rapidly progressing necrotic eschars and severe neutropenia.
Shobha Maharjan +2 more
wiley +1 more source
Development of dengue DNA vaccines
Vaccine, 2011 Vaccination with plasmid DNA against infectious pathogens including dengue is an active area of investigation. By design, DNA vaccines are able to elicit both antibody responses and cellular immune responses capable of mediating long-term protection. Great technical improvements have been made in dengue DNA vaccine constructs and trials are underway to
Danko, Janine R. +2 more
openaire +3 more sources
PLoS Neglected Tropical DiseasesBackgroundDengue infection is endemic in Thailand, with children being the most impacted group. Various measures, including the dengue vaccine (recently recommended in Thailand since 2017 for Dengvaxia and 2023 for Qdenga), have been implemented to ...
Donruedee Kamkhoad +3 more
doaj +1 more source
Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity
, 2014 [[abstract]]The combination of recombinant protein antigens with an immunostimulator has the potential to greatly increase the immunogenicity of recombinant protein antigens. In the present study, we selected the dengue-4 envelope protein domain III as a
Chiang, CY;Hsieh, CH;Chen, MY;Tsai, JP;Liu, HH;Liu, SJ;Chong, P;Leng, CH;Chen, HW
core +1 more source
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background Dengue (DG) is a growing global public health threat. Bangladesh continues to endure an increasing burden despite persistent vector‐control initiatives. Effective DG prevention relies on adequate community knowledge, favorable attitudes, and sustained protective practices.
Abu Reza Md. Towfiqul Islam +2 more
wiley +1 more source
Dengue vaccine acceptance and willingness to pay
Human Vaccines & Immunotherapeutics, 2017 The introduction of new vaccines is accompanied by a variety of challenges. Among these, very important ones concern the questions whether the public is willing to accept and willing to purchase the vaccine.
Harapan Harapan +3 more
doaj +1 more source
Anti-dengue Vaccines: From Development to Clinical Trials
Frontiers in Immunology, 2020 Dengue Virus (DENV) is an arbovirus (arthropod-borne virus). Four serotypes of DENV are responsible for the infectious disease called dengue that annually affects nearly 400 million people worldwide.
Josilene Ramos Pinheiro-Michelsen +9 more
doaj +1 more source
Pharmacy‐Based Immunization Delivery: A Comprehensive History and Current Challenges
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 6, June 2026.ABSTRACT Pharmacists and their teams have a long history of involvement with vaccines. This paper describes the contributions of pharmacy‐based immunization delivery in the United States from the 1800's to date. Early activities centered around storage and distribution of antitoxins and vaccines. From the 1950s through the early 1990s, pharmacists were
Jean‐Venable R. Goode +4 more
wiley +1 more source
Reverse Genetics of Orthoflaviviruses: Strategies for Constructing Functional or Infectious cDNA
Journal of Medical Virology, Volume 98, Issue 6, June 2026.ABSTRACT Reverse genetics (RG) systems have transformed RNA virus research by enabling the recovery of recombinant viruses entirely from cloned cDNA. These platforms allow precise, hypothesis‐driven manipulation of viral genomes and support systematic phenotypic analyses in vitro and in vivo.
Young‐Min Lee
wiley +1 more source